Please use this identifier to cite or link to this item:
Title: The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration.
Austin Authors: Banerjee, S;Lim, K H J;Murali, K;Kamposioras, K;Punie, K;Oing, C;O'Connor, M;Thorne, E;Devnani, B;Lambertini, M;Westphalen, C B;Garrido, P;Amaral, T;Morgan, G;Haanen, J B A G;Hardy, C
Affiliation: Department of Immunology and Inflammation, Imperial College London, London, UK
The Institute of Cancer Research, London, UK
Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Portuguese Air Force Health Care Direction, Lisbon, Portugal
Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy
Austin Health
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium
Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
University Hospital Waterford, Waterford, Ireland
Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK
Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India
Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany
Medical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain
Department of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden
Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK
Issue Date: 4-Feb-2021
Date: 2021-02-04
Publication information: ESMO Open 2021; 6(2): 100058
Abstract: The impact of the coronavirus disease 2019 (COVID-19) pandemic on well-being has the potential for serious negative consequences on work, home life, and patient care. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate well-being in oncology over time since COVID-19. Two online anonymous surveys were conducted (survey I: April/May 2020; survey II: July/August 2020). Statistical analyses were performed to examine group differences, associations, and predictors of key outcomes: (i) well-being/distress [expanded Well-being Index (eWBI; 9 items)]; (ii) burnout (1 item from eWBI); (iii) job performance since COVID-19 (JP-CV; 2 items). Responses from survey I (1520 participants from 101 countries) indicate that COVID-19 is impacting oncology professionals; in particular, 25% of participants indicated being at risk of distress (poor well-being, eWBI ≥ 4), 38% reported feeling burnout, and 66% reported not being able to perform their job compared with the pre-COVID-19 period. Higher JP-CV was associated with better well-being and not feeling burnout (P < 0.01). Differences were seen in well-being and JP-CV between countries (P < 0.001) and were related to country COVID-19 crude mortality rate (P < 0.05). Consistent predictors of well-being, burnout, and JP-CV were psychological resilience and changes to work hours. In survey II, among 272 participants who completed both surveys, while JP-CV improved (38% versus 54%, P < 0.001), eWBI scores ≥4 and burnout rates were significantly higher compared with survey I (22% versus 31%, P = 0.01; and 35% versus 49%, P = 0.001, respectively), suggesting well-being and burnout have worsened over a 3-month period during the COVID-19 pandemic. In the first and largest global survey series, COVID-19 is impacting well-being and job performance of oncology professionals. JP-CV has improved but risk of distress and burnout has increased over time. Urgent measures to address well-being and improve resilience are essential.
DOI: 10.1016/j.esmoop.2021.100058
Journal: ESMO Open
PubMed URL: 33601295
Type: Journal Article
Subjects: COVID-19
job performance
oncology professionals
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on May 28, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.